tiprankstipranks
Trending News
More News >
Vivoryon Therapeutics AG (NL:VVY)
:VVY
Netherlands Market

Vivoryon Therapeutics AG (VVY) Technical Analysis

Compare
2 Followers

Summary of all the Indicators

Overall Consensus
Neutral
9Bullish
5Neutral
8Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Vivoryon Therapeutics AG’s (VVY) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Vivoryon Therapeutics AG is a Sell.
Vivoryon Therapeutics AG’s (VVY) 20-Day exponential moving average is 1.53, while Vivoryon Therapeutics AG’s (VVY) share price is €1.45, making it a Buy.
Vivoryon Therapeutics AG’s (VVY) 50-Day exponential moving average is 1.56, while Vivoryon Therapeutics AG’s (VVY) share price is €1.45, making it a Buy.

Vivoryon Therapeutics AG (VVY) Pivot Points

Jan 11, 2026, 07:03 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.43
1.47
1.53
1.56
1.63
1.66
1.72
Fibonacci
1.47
1.50
1.53
1.56
1.60
1.62
1.66
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Vivoryon Therapeutics AG (VVY) Moving Averages

Jan 11, 2026, 07:03 PM
Period
Simple
Exponential
MA5
1.56Sell
1.55Buy
MA10
1.50Buy
1.53Buy
MA20
1.51Buy
1.53Buy
MA50
1.58Sell
1.56Buy
MA100
1.60Sell
1.58Sell
MA200
1.61Sell
1.66Sell
Vivoryon Therapeutics AG’s (VVY) 10-Day exponential moving average is 1.53, while Vivoryon Therapeutics AG’s (VVY) share price is €1.45, making it a Buy.
Vivoryon Therapeutics AG’s (VVY) 100-Day exponential moving average is 1.58, while Vivoryon Therapeutics AG’s (VVY) share price is €1.45, making it a Sell.
Vivoryon Therapeutics AG’s (VVY) stock price is €1.45 and Vivoryon Therapeutics AG’s (VVY) 50-day simple moving average is 1.58, creating a Sell signal.
Vivoryon Therapeutics AG’s (VVY) stock price is €1.45 and Vivoryon Therapeutics AG’s (VVY) 100-day simple moving average is 1.60, creating a Sell signal.
Vivoryon Therapeutics AG’s (VVY) stock price is €1.45 and Vivoryon Therapeutics AG’s (VVY) 200-day simple moving average is 1.61, creating a Sell signal.

Vivoryon Therapeutics AG (VVY) Technical Indicators

Jan 11, 2026, 07:03 PM
Name
Value
Implied Action
RSI (14)
54.14
Neutral
STOCH (9,6)
71.88
Neutral
STOCHRSI (14)
71.88
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
32.47
Neutral
Williams %R
-38.26
Buy
CCI (14)
102.49
Sell
ATR (14)
0.05
-
Ultimate Oscillator
58.96
Neutral
ROC
4.00
Buy
Vivoryon Therapeutics AG’s (VVY) Relative Strength Index (RSI) is 54.14, creating a Neutral signal.
Vivoryon Therapeutics AG’s (VVY) Trend Strength Indicator (ADX) is 32.47, creating a Neutral signal.
Vivoryon Therapeutics AG’s (VVY) Commodity Channel Index (CCI) is 102.49, creating a Sell signal.
Vivoryon Therapeutics AG’s (VVY) Price Rate of Change (ROC) is 4.00, creating a Buy signal.

FAQ

Is VVY a Buy, Hold, or Sell?
Based on VVY’s technical indicators, VVY is a Hold.
    What is VVY’s RSI (14)?
    VVY’s RSI (14) is 54.14, which suggests VVY is a Neutral.
      What is VVY’s MACD?
      VVY’s MACD is >-0.01, which suggests VVY is a Sell.
        What is VVY’s 5-day moving average?
        VVY’s 5-day moving average is 1.56, which suggests VVY is a Sell.
          What is VVY’s 20-day moving average?
          VVY 20-day moving average is 1.51, which suggests VVY is a Buy.
            What is VVY’s 50-day moving average?
            VVY’s 50-day moving average is 1.58, which suggests VVY is a Sell.
              What is VVY’s 200-day moving average?
              VVY’s 200-day moving average is 1.61, which suggests VVY is a Sell.
                What is VVY’s Williams % R (14)?
                VVY’s Williams % R (14) is -38.26, which suggests VVY is a Buy.
                  What is VVY’s CCI (14)?
                  VVY’s CCI (14) is 102.49, which suggests VVY is a Sell.
                    What is the share price of Vivoryon Therapeutics AG?